A Strategy to Detect Emerging Non-Delta SARS-CoV-2 Variants with a Monoclonal Antibody Specific for the N501 Spike Residue
- Supplementary File 1:
ZIP-Document (ZIP, 535 KiB)
Puligedda, R.D.; Al-Saleem, F.H.; Wirblich, C.; Kattala, C.D.; Jović, M.; Geiszler, L.; Devabhaktuni, H.; Feuerstein, G.Z.; Schnell, M.J.; Sack, M.; Livornese, L.L., Jr.; Dessain, S.K. A Strategy to Detect Emerging Non-Delta SARS-CoV-2 Variants with a Monoclonal Antibody Specific for the N501 Spike Residue. Diagnostics 2021, 11, 2092. https://doi.org/10.3390/diagnostics11112092
Puligedda RD, Al-Saleem FH, Wirblich C, Kattala CD, Jović M, Geiszler L, Devabhaktuni H, Feuerstein GZ, Schnell MJ, Sack M, Livornese LL Jr., Dessain SK. A Strategy to Detect Emerging Non-Delta SARS-CoV-2 Variants with a Monoclonal Antibody Specific for the N501 Spike Residue. Diagnostics. 2021; 11(11):2092. https://doi.org/10.3390/diagnostics11112092
Chicago/Turabian StylePuligedda, Rama Devudu, Fetweh H. Al-Saleem, Cristoph Wirblich, Chandana Devi Kattala, Marko Jović, Laura Geiszler, Himani Devabhaktuni, Giora Z. Feuerstein, Matthias J. Schnell, Markus Sack, Lawrence L. Livornese Jr., and Scott K. Dessain. 2021. "A Strategy to Detect Emerging Non-Delta SARS-CoV-2 Variants with a Monoclonal Antibody Specific for the N501 Spike Residue" Diagnostics 11, no. 11: 2092. https://doi.org/10.3390/diagnostics11112092